These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26297692)

  • 1. Physiologically based pharmacokinetic modeling of ethyl acetate and ethanol in rodents and humans.
    Crowell SR; Smith JN; Creim JA; Faber W; Teeguarden JG
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):452-62. PubMed ID: 26297692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking internal dosimetries of the propyl metabolic series in rats and humans using physiologically based pharmacokinetic (PBPK) modeling.
    Smith JN; Tyrrell KJ; Smith JP; Weitz KK; Faber W
    Regul Toxicol Pharmacol; 2020 Feb; 110():104507. PubMed ID: 31669189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PBPK model for evaluating the impact of aldehyde dehydrogenase polymorphisms on comparative rat and human nasal tissue acetaldehyde dosimetry.
    Teeguarden JG; Bogdanffy MS; Covington TR; Tan C; Jarabek AM
    Inhal Toxicol; 2008 Feb; 20(4):375-90. PubMed ID: 18302046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route-to-route extrapolation of 1,2-dichloroethane studies from the oral route to inhalation using physiologically based pharmacokinetic models.
    Sweeney LM; Gargas ML
    Regul Toxicol Pharmacol; 2016 Nov; 81():468-479. PubMed ID: 27756559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biologically based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity.
    Bogdanffy MS; Sarangapani R; Plowchalk DR; Jarabek A; Andersen ME
    Toxicol Sci; 1999 Sep; 51(1):19-35. PubMed ID: 10496674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.
    Poet TS; Schlosser PM; Rodriguez CE; Parod RJ; Rodwell DE; Kirman CR
    Regul Toxicol Pharmacol; 2016 Apr; 76():102-12. PubMed ID: 26776754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an inhalation physiologically based pharmacokinetic (PBPK) model for 2,2, 4-trimethylpentane (TMP) in male Long-Evans rats using gas uptake experiments.
    El-Masri HA; Dowd S; Pegram RA; Harrison R; Yavanhxay SJ; Simmons JE; Evans M
    Inhal Toxicol; 2009 Dec; 21(14):1176-85. PubMed ID: 19922404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model.
    MacDonald AJ; Rostami-Hodjegan A; Tucker GT; Linkens DA
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):165-76. PubMed ID: 12052002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBPK modeling characterization of potential acute impairment effects from inhalation of ethanol during e-cigarette use.
    More SL; Thornton SA; Maskrey JR; Sharma A; de Gandiaga E; Cheng TJ; Fung ES; Bernal AJ; Madl AK
    Inhal Toxicol; 2020 Jan; 32(1):14-23. PubMed ID: 32013640
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal workplace accident involving ethyl acetate: a distribution study.
    Coopman VA; Cordonnier JA; De Meyere CA
    Forensic Sci Int; 2005 Nov; 154(2-3):92-5. PubMed ID: 16182954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based pharmacokinetic modeling for 1-bromopropane in F344 rats using gas uptake inhalation experiments.
    Garner CE; Liang S; Yin L; Yu X
    Toxicol Sci; 2015 May; 145(1):23-36. PubMed ID: 25634537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically based pharmacokinetic modeling of inhaled 2-butoxyethanol in man.
    Johanson G
    Toxicol Lett; 1986 Nov; 34(1):23-31. PubMed ID: 3787662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family approach for estimating reference concentrations/doses for series of related organic chemicals.
    Barton HA; Deisinger PJ; English JC; Gearhart JN; Faber WD; Tyler TR; Banton MI; Teeguarden J; Andersen ME
    Toxicol Sci; 2000 Mar; 54(1):251-61. PubMed ID: 10746952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic study of ethanol and its metabolites during ethanol infusion.
    Fujimiya T; Ohbora Y; Shinagawa H; Aki T
    Leg Med (Tokyo); 2003 Mar; 5 Suppl 1():S126-8. PubMed ID: 12935569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic products of [2-(13) C]ethanol in the rat brain after chronic ethanol exposure.
    Wang J; Du H; Ma X; Pittman B; Castracane L; Li TK; Behar KL; Mason GF
    J Neurochem; 2013 Nov; 127(3):353-64. PubMed ID: 24033360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data.
    Dallas CE; Chen XM; O'Barr K; Muralidhara S; Varkonyi P; Bruckner JV
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):50-9. PubMed ID: 8079354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 2-phenoxyethanol and its major metabolite, phenoxyacetic acid, after dermal and inhaled routes of exposure: application to development PBPK model in rats.
    Kwon M; Park JB; Kwon M; Song J; Yeo CS; Bae SH
    Arch Toxicol; 2021 Jun; 95(6):2019-2036. PubMed ID: 33844041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-chamber inhalation pharmacokinetic studies with hexamethyldisiloxane in the rat.
    Dobrev ID; Reddy MB; Plotzke KP; Varaprath S; McNett DA; Durham J; Andersen ME
    Inhal Toxicol; 2003 May; 15(6):589-617. PubMed ID: 12692732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a physiologically based pharmacokinetic model to estimate the bioavailability of ethanol in male rats: distinction between gastric and hepatic pathways of metabolic clearance.
    Pastino GM; Conolly RB
    Toxicol Sci; 2000 Jun; 55(2):256-65. PubMed ID: 10828256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling.
    Kirman CR; Sweeney LM; Meek ME; Gargas ML
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):345-67. PubMed ID: 14623485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.